Medical Device Electronic Labeling Act
Summary
What This Bill Does
The Medical Device Electronic Labeling Act rewrites the Food, Drug, and Cosmetic Act labeling requirement for devices. Required labeling for devices, including in vitro diagnostic devices, may be made available solely by electronic means if the labeling is readily accessible to intended users. Manufacturers must give intended users an opportunity to request paper labeling and must promptly provide it upon request. The bill moves device labeling toward digital access while preserving a paper fallback. It matters for device manufacturers that ship bulky instructions, hospitals and labs that manage device documentation, users without reliable digital access, and FDA officials responsible for labeling compliance.
Who Benefits and How
Medical device manufacturers benefit because electronic-only labeling can reduce printing, packaging, and update costs. In vitro diagnostic manufacturers benefit because rapidly changing instructions can be updated digitally rather than through paper inserts. Hospitals benefit if electronic labeling makes device instructions easier to search, store, and update. Clinical laboratories benefit from digital access to current labeling for diagnostic devices used in testing workflows.
Who Bears the Burden and How
Device users without reliable internet or digital tools may face access barriers unless they request paper labeling. Manufacturers must maintain readily accessible electronic labeling and fulfill paper-copy requests promptly. FDA must oversee compliance with electronic-access and paper-request safeguards. Health care compliance staff must ensure clinicians can retrieve required warnings and directions when needed.
Key Provisions
- Authorizes device labeling to be made available solely by electronic means.
- Includes in vitro diagnostic devices in the electronic-labeling authority.
- Requires labeling to be readily accessible to intended users.
- Requires manufacturers to provide paper labeling promptly when intended users request it.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
Allows medical device and in vitro diagnostic labeling required under the Food, Drug, and Cosmetic Act to be supplied solely by electronic means when users can readily access it and request paper copies.
Key Policy Areas
FDA, Medical Devices, Digital Labeling
Primary Purpose
Allows medical device and in vitro diagnostic labeling required under the Food, Drug, and Cosmetic Act to be supplied solely by electronic means when users can readily access it and request paper copies.
Policy Domains
Resolution provisions
Identified Gains
- Medical device manufacturers
- In vitro diagnostic manufacturers
- Hospitals
- Clinical laboratories
Identified Costs
- Digitally limited device users
- Device manufacturers
- FDA
- Health care compliance staff
Sponsors
Legislative Progress
In CommitteeMr. Obernolte (for himself, Mr. Mullin, Mr. Crenshaw, and Ms. …
Referred to the House Committee on Energy and Commerce.
Introduced in House
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Diagnostic test manufacturers, Digitally limited device users, Hospitals
Positive-direction: Diagnostic test manufacturers, Hospitals, Medical device manufacturers
Negative-direction: Digitally limited device users
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology